Skip to main content
. 2024 Nov 26;15:1470037. doi: 10.3389/fmicb.2024.1470037

Figure 3.

Figure 3

Differentially abundant ASVs between (A) HIV(−)/injectors compared to HIV(+)/injectors (B) HIV(+)/non-injectors compared to HIV(+)/injectors (C) HIV(−)/non-injectors compared to HIV(+)/injectors.